NCT04599075View on ClinicalTrials.gov

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

May 1, 2023

Study Completion Date

May 2, 2023

Conditions

Type 1 DiabetesPregnancy, High Risk

Interventions

DRUG

Insulin

IV Insulin Infusion

DRUG

Insulin

Continuous Subcutaneous Insulin Infusion (Pump)

Trial Locations (1)

01605

University of Massachusetts Memorial Medical Center, Worcester

All Listed Sponsors

lead

Gianna Wilkie

OTHER

NCT04599075 - Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter